Histiocytic Sarcoma — Clinical Trials

MONDO:00194793 active·1 recruitingLast updated: Mar 19, 2026, 10:36 AM

Trial Landscape

Histiocytic Sarcoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment4

Procedure2

2 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other3NIH1

Trial Locations

United States4 trials

Australia1 trial

Canada1 trial

Puerto Rico1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Phase 2Recruiting

NCT04079179

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Sponsor:Carl Allen

United StatesStarted: Apr 2021Est. completion: Dec 2029Updated: Sep 2025

Phase 2Active, Not Recruiting

NCT03155620

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jul 2017Est. completion: Jan 2027Updated: Feb 2026

Phase 2Active, Not Recruiting

NCT02523040

Lenalidomide for Adult Histiocyte Disorders

Sponsor:Dana-Farber Cancer Institute

United StatesStarted: Aug 2015Est. completion: Feb 2026Updated: Dec 2025

Stay informed about clinical trials for Histiocytic Sarcoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 19, 2026 at 10:36 AM